Phase 2 Pseudomonas aeruginosa Clinical Trials

4 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–4 of 4 trials

Recruiting

Phase 2

A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

Bronchiectasis With Pseudomonas Aeruginosa Colonization

AstraZeneca435 enrolled183 locationsNCT07088926

Recruiting

Phase 1Phase 2

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Pseudomonas aeruginosaCystic Fibrosis LungRespiratory Infections, Recurrent, Chronic

Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088

Recruiting

Phase 2

Study With Phage for CF Subjects With Pseudomonas Lung Infection

Cystic Fibrosis (CF)Chronic Pseudomonas Aeruginosa Infection

BiomX Ltd63 enrolled14 locationsNCT06998043

Terminated

Phase 2

Effect of adding calcium salt of ethylene diamine tetra-acetate (CaEDTA) to nebulised tobramycin on bacterial clearance and lung function in patients with cystic fibrosis with chronic Pseudomonas aeruginosa lung infections: a randomised controlled trial..

Pseudomonas aeruginosa

Telethon Kids Institute32 enrolled2 locationsACTRN12620000531910